vs
Side-by-side financial comparison of KOSS CORP (KOSS) and MAXCYTE, INC. (MXCT). Click either name above to swap in a different company.
MAXCYTE, INC. is the larger business by last-quarter revenue ($4.8M vs $2.9M, roughly 1.7× KOSS CORP). KOSS CORP runs the higher net margin — -19.8% vs -200.5%, a 180.7% gap on every dollar of revenue. On growth, KOSS CORP posted the faster year-over-year revenue change (-19.6% vs -20.9%). KOSS CORP produced more free cash flow last quarter ($-1.1M vs $-2.9M). Over the past eight quarters, KOSS CORP's revenue compounded faster (4.2% CAGR vs -7.4%).
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
MaxCyte Inc. is a global biotechnology company focused on developing cell engineering platforms and enabling technologies for cell and gene therapy advancement. Its proprietary non-viral cell modification systems are widely used by pharmaceutical, biotech and life science research entities to develop immunotherapies, gene-edited treatments and next-generation biologic drugs from preclinical research through commercialization.
KOSS vs MXCT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9M | $4.8M |
| Net Profit | $-565.4K | $-9.6M |
| Gross Margin | 29.0% | — |
| Operating Margin | -35.5% | -234.5% |
| Net Margin | -19.8% | -200.5% |
| Revenue YoY | -19.6% | -20.9% |
| Net Profit YoY | -700.6% | 9.4% |
| EPS (diluted) | $-0.06 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9M | $4.8M | ||
| Q3 25 | $4.1M | $4.6M | ||
| Q2 25 | $3.1M | $5.8M | ||
| Q1 25 | $2.8M | $5.7M | ||
| Q4 24 | $3.6M | $6.1M | ||
| Q3 24 | $3.2M | $5.6M | ||
| Q2 24 | $2.9M | $5.0M | ||
| Q1 24 | $2.6M | $5.6M |
| Q4 25 | $-565.4K | $-9.6M | ||
| Q3 25 | $243.7K | $-12.4M | ||
| Q2 25 | $-232.7K | $-12.4M | ||
| Q1 25 | $-316.7K | $-10.3M | ||
| Q4 24 | $94.1K | $-10.6M | ||
| Q3 24 | $-419.5K | $-11.6M | ||
| Q2 24 | $-110.4K | $-9.4M | ||
| Q1 24 | $-313.8K | $-9.5M |
| Q4 25 | 29.0% | — | ||
| Q3 25 | 40.0% | — | ||
| Q2 25 | 36.0% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 39.5% | — | ||
| Q3 24 | 36.6% | — | ||
| Q2 24 | 40.4% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -35.5% | -234.5% | ||
| Q3 25 | -1.1% | -307.4% | ||
| Q2 25 | -14.2% | -244.3% | ||
| Q1 25 | -18.7% | -214.1% | ||
| Q4 24 | -4.0% | -213.1% | ||
| Q3 24 | -19.9% | -250.4% | ||
| Q2 24 | -11.0% | -241.0% | ||
| Q1 24 | -23.1% | -219.8% |
| Q4 25 | -19.8% | -200.5% | ||
| Q3 25 | 6.0% | -269.7% | ||
| Q2 25 | -7.5% | -212.2% | ||
| Q1 25 | -11.4% | -178.7% | ||
| Q4 24 | 2.6% | -175.0% | ||
| Q3 24 | -13.1% | -205.9% | ||
| Q2 24 | -3.8% | -188.8% | ||
| Q1 24 | -11.9% | -170.6% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | $-0.12 | ||
| Q2 25 | $-0.02 | $-0.12 | ||
| Q1 25 | $-0.03 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.05 | $-0.11 | ||
| Q2 24 | $-0.01 | $-0.09 | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $103.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $30.3M | $171.5M |
| Total Assets | $36.8M | $202.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.5M | $103.0M | ||
| Q3 25 | $16.5M | $105.7M | ||
| Q2 25 | $15.7M | $126.6M | ||
| Q1 25 | $13.0M | $138.3M | ||
| Q4 24 | $9.7M | $154.5M | ||
| Q3 24 | $11.9M | $153.8M | ||
| Q2 24 | $14.9M | $157.3M | ||
| Q1 24 | $9.9M | $157.5M |
| Q4 25 | $30.3M | $171.5M | ||
| Q3 25 | $30.9M | $180.3M | ||
| Q2 25 | $30.6M | $190.7M | ||
| Q1 25 | $30.7M | $199.4M | ||
| Q4 24 | $31.0M | $206.3M | ||
| Q3 24 | $30.8M | $213.3M | ||
| Q2 24 | $31.1M | $221.3M | ||
| Q1 24 | $31.1M | $226.4M |
| Q4 25 | $36.8M | $202.5M | ||
| Q3 25 | $37.7M | $213.5M | ||
| Q2 25 | $37.2M | $219.8M | ||
| Q1 25 | $37.3M | $230.0M | ||
| Q4 24 | $37.4M | $239.5M | ||
| Q3 24 | $38.1M | $248.6M | ||
| Q2 24 | $37.2M | $251.5M | ||
| Q1 24 | $37.6M | $257.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-760.8K | $-2.7M |
| Free Cash FlowOCF − Capex | $-1.1M | $-2.9M |
| FCF MarginFCF / Revenue | -37.5% | -61.0% |
| Capex IntensityCapex / Revenue | 10.9% | 4.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-546.7K | $-36.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-760.8K | $-2.7M | ||
| Q3 25 | $762.6K | $-7.5M | ||
| Q2 25 | $-534.9K | $-9.9M | ||
| Q1 25 | $370.4K | $-14.4M | ||
| Q4 24 | $-252.0K | $-7.8M | ||
| Q3 24 | $201.6K | $-4.4M | ||
| Q2 24 | $-174.0K | $-4.8M | ||
| Q1 24 | $328.6K | $-10.6M |
| Q4 25 | $-1.1M | $-2.9M | ||
| Q3 25 | $761.5K | $-7.8M | ||
| Q2 25 | $-541.8K | $-10.4M | ||
| Q1 25 | $306.2K | $-15.1M | ||
| Q4 24 | $-314.3K | $-8.0M | ||
| Q3 24 | $-155.6K | $-4.8M | ||
| Q2 24 | $-174.8K | $-5.1M | ||
| Q1 24 | $269.3K | $-11.4M |
| Q4 25 | -37.5% | -61.0% | ||
| Q3 25 | 18.7% | -168.5% | ||
| Q2 25 | -17.6% | -179.2% | ||
| Q1 25 | 11.0% | -262.3% | ||
| Q4 24 | -8.8% | -131.6% | ||
| Q3 24 | -4.9% | -85.5% | ||
| Q2 24 | -6.0% | -103.3% | ||
| Q1 24 | 10.2% | -203.6% |
| Q4 25 | 10.9% | 4.8% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 0.2% | 10.0% | ||
| Q1 25 | 2.3% | 11.4% | ||
| Q4 24 | 1.8% | 2.4% | ||
| Q3 24 | 11.2% | 7.2% | ||
| Q2 24 | 0.0% | 5.9% | ||
| Q1 24 | 2.3% | 14.4% |
| Q4 25 | — | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KOSS
Segment breakdown not available.
MXCT
| Products | $4.2M | 87% |
| Other | $634.0K | 13% |
